Comparative Study of Pharmacology of a New Myocardial Imaging Agent [99tcm(co)3(mibi)3]+ and 99 Tcm-MIBI

王金城,刘伯里,米宏志,蒋燕,唐志刚,归海旼

DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2002.04.015

2002-01-01

Abstract:Objective To study the biological properties of a new myocardial perfusion imaging agent [ 99 Tc m(CO) 3(MIBI) 3] + in animal and to compare it with 99 Tc m methoxyisobutylisonitrile (MIBI). Methods Solution of [ 99 Tc m(CO) 3(MIBI) 3] + for intravenous injection was prepared. The radiochemical purity was 85% and labelling percentage was over 90%. Three dogs were involved, the dose of [ 99 Tc m(CO) 3(MIBI) 3] + for each dog was 555 MBq at each time of experiment. The pharmacokinetics, biodistribution, ratio of T/NT and myocardial imaging were investigated. Results The pharmacokinetics of [ 99 Tc m(CO) 3(MIBI) 3] + conformed to two compartment model, T(α) 1/2 =(1.33±0.12) min, T(β) 1/2 =(102.33±25.58) min, CL=(401.33±73.51) mL/h. The time radioactivity curves showed that the liver uptake curves of [ 99 Tc m(CO) 3(MIBI) 3] + were below the myocardial curves, while that of 99 Tc m MIBI were above the myocardial curves. The myocardial uptake %ID at 10, 30, 60, 90 and 120 min, and heart to lung and heart to liver activity ratio of the new agent were higher compared with 99 Tc m MIBI. The planar and SPECT images of [ 99 Tc m(CO) 3(MIBI) 3] + during 10 to 120 min showed with good quality with lower lung and liver radioactivities. Conclusion The results of this study show that the [ 99 Tc m(CO) 3(MIBI) 3] + is better than 99 Tc m MIBI in myocardial imaging and warrant further investigation as a potential myocardial perfusion imaging agent.